Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -2.21x is 68% above its 5-year average of -6.97x, around the middle of its 5-year range (-87.67x–64.35x).
74.14% below its 12-month average of -1.27x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 0.50x.
INTEREST COVERAGE RATIO
-2.21x
INTEREST COVERAGE RATIO AVG TTM
-1.27x
INTEREST COVERAGE RATIO AVG 3Y
-2.65x
INTEREST COVERAGE RATIO AVG 5Y
-6.97x
INTEREST COVERAGE RATIO AVG 10Y
-7.33x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-74.14%
CURRENT VS 3Y AVG
+16.69%
CURRENT VS 5Y AVG
+68.31%
CURRENT VS 10Y AVG
+69.85%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.21x
median of 340 covered companies
CURRENT VS SECTOR MEDIAN
+47.51%
vs the sector median at left
Journey Medical Corporation
Market Cap
$183.71M
Interest Coverage Ratio
-2.21x
TTM Avg
-1.27x
3Y Avg
-2.65x
5Y Avg
-6.97x
Market Cap
$178.54M
Interest Coverage Ratio
-709.33x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$177.29M
Interest Coverage Ratio
-74.29x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$193.74M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$173.34M
Interest Coverage Ratio
-36.67x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$194.49M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$171.61M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$169.95M
Interest Coverage Ratio
-19.95x
TTM Avg
6.75x
3Y Avg
6.75x
5Y Avg
6.75x
Market Cap
$203.00M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Journey Medical Corporation (DERM) | $183.71M | -2.21x | -1.27x | -2.65x | -6.97x |
| Canton Strategic Holdings Inc (CNTN)vs › | $178.54M | -709.33x | N/A | N/A | N/A |
| Cue Biopharma, Inc. (CUE)vs › | $177.29M | -74.29x | N/A | N/A | N/A |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $193.74M | N/A | N/A | N/A | N/A |
| Precision BioSciences, Inc. (DTIL)vs › | $173.34M | -36.67x | N/A | N/A | N/A |
| AN2 Therapeutics, Inc. (ANTX)vs › | $194.49M | N/A | N/A | N/A | N/A |
| Compass Therapeutics, Inc. (CMPX)vs › | $171.61M | N/A | N/A | N/A | N/A |
| Coherus Oncology, Inc. (CHRS)vs › | $169.95M | -19.95x | 6.75x | 6.75x | 6.75x |
| Electra Therapeutics Inc. (ETRA)vs › | $203.00M | N/A | N/A | N/A | N/A |
| Inogen, Inc. (INGN)vs › | $161.12M | N/A | 2247.41x | 1131.54x | 905.57x |
Interest Coverage
-2.2x
Debt/Equity
0.80
Current Ratio
1.59
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 0.50x |
| 2026-03-31 | -1.67x |
| 2025-12-31 | -0.47x |
| 2025-09-30 | -1.63x |
| 2025-06-30 | -3.07x |
| 2025-03-31 | -3.73x |
| 2024-12-31 | 2.69x |
| 2024-09-30 | -3.82x |
| 2024-06-30 | -5.20x |
| 2024-03-31 | -18.41x |
| 2023-12-31 | -87.67x |
| 2023-09-30 | 64.35x |
| 2023-06-30 | -10.12x |
| 2023-03-31 | -14.71x |
| 2022-12-31 | -16.20x |
| 2022-09-30 | -16.98x |
| 2022-06-30 | -15.73x |
| 2022-03-31 | -2.28x |
| 2021-12-31 | -2.21x |
| 2021-09-30 | -9.21x |
| 2021-06-30 | -10.26x |
| 2021-03-31 | 2.65x |
| 2020-12-31 | 17.60x |
| 2020-09-30 | 1.28x |
| 2020-06-30 | 9.93x |
| 2019-09-30 | -12.54x |
| 2019-06-30 | -4.49x |
| 2019-03-31 | -17.13x |
| 2018-12-31 | -21.82x |
| 2018-09-30 | -19.10x |
| 2018-06-30 | -4.49x |
| 2018-03-31 | -13.38x |
| 2017-12-31 | -13.57x |
| 2017-09-30 | -62.16x |
| 2017-06-30 | -29.17x |
| 2016-12-31 | -5.12x |
| 2015-12-31 | -997.47x |
| 2015-09-30 | -417.28x |
| 2015-06-30 | -834.24x |
| 2015-03-31 | -374.58x |
| 2014-12-31 | 638.87x |
